Cargando…

Successful Medical Management of a Non-Localising Case of Tumour-Induced Osteomalacia

Introduction: TIO is a rare paraneoplastic syndrome characterised by renal phosphate wasting due to fibroblast growth factor-23 (FGF23) over-secretion from a phosphaturic mesenchymal tumour (PMT). While surgery is potentially curative, localisation is often challenging. Clinical Case: A 53 year old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan Hoong, Caroline Wei, Mok, Shao Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089362/ http://dx.doi.org/10.1210/jendso/bvab048.458

Ejemplares similares

Tumor Induced Osteomalacia - Long Term Medical Treatment When Surgery Is Risky
por: Levy, Shiri, et al.
Publicado: (2021)

Sternal Phosphaturic Mesenchymal Tumor-Induced Osteomalacia, Diagnosis and Management: A Case Report
por: Adeyemo, Mopelola Adetola, et al.
Publicado: (2021)

MON-501 A Hemangioma Causing Tumor Induced Osteomalacia
por: Chinnakotla, Venkata Sai Bhavana, et al.
Publicado: (2019)

MON-502 It's Not Always Osteoporosis: FGF-23 Induced Osteomalacia
por: Bello Segura, Manuel, et al.
Publicado: (2019)

MON-353 Tumor-Induced Osteomalacia from a Hypervascular Thoracic Paraspinal Mass: Challenges in Diagnosis and Management
por: Perez, Paola M, et al.
Publicado: (2020)

SAT-337 Ga-DOTATATE and Tumor Induced Osteomalacia: Finding the Culprit Lesion
por: Berman, Jessica, et al.
Publicado: (2020)

MON-352 When Osteoporosis Does Not Make Sense: Tumor-Induced Osteomalacia
por: Techathaveewat, Pawarid, et al.
Publicado: (2020)

Severe Osteomalacia and Fractures Secondary to Vitamin D Deficiency
por: Mathew, Justin, et al.
Publicado: (2021)

MON-500 A Case of Tumor-Induced Osteomalacia Caused by Metastatic Prostate Cancer
por: Rahman, Wedad, et al.
Publicado: (2019)

Tumor Induced Osteomalacia in Patients With Metastatic Prostate Cancer: Case Report and Literature Review
por: Khadilkar, Arjun, et al.
Publicado: (2021)

ODP125 Soft Bones in Crohn's: Tumor-induced osteomalacia and inflammatory bowel disease
por: Habbsa, Samima, et al.
Publicado: (2022)

THU464 An Uncommon Case Of Adult-Onset Hypophosphatemic Osteomalacia
por: Lockhart, Paola M, et al.
Publicado: (2023)

MON-499 Tumor Induced Osteomalacia: (68)Ga-DOTATATE PET/CT Scan For Localization
por: Thangavelu, Thiyagarajan, et al.
Publicado: (2019)

OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome
por: Jan De Beur, Suzanne, et al.
Publicado: (2019)

SAT-385 A Normal FGF23 Does Not Preclude Tumor Induced Osteomalacia (TIO)
por: Nandam, Neeharika, et al.
Publicado: (2020)

OR29-06 Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome
por: Carpenter, Thomas O, et al.
Publicado: (2020)

THU465 Significant Improvement In Bone Mineral Density Following Treatment For Tumor Induced Osteomalacia
por: McHan, Lara C, et al.
Publicado: (2023)

SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia
por: Gafni, Rachel Ilana, et al.
Publicado: (2020)

Diagnostic Dilemma of Elevated FGF23 in a Patient With Osteomalacia: A Case Report
por: Bulut, Aysegul, et al.
Publicado: (2021)

MON-364 Severe Postoperative Encephalopathy in a Patient with Oncogenic Osteomalacia and Neurofibromatosis Type 1
por: Sarkar, Sauradeep, et al.
Publicado: (2020)

Favorable Effects of Burosumab on Fibroblast Growth Factor 23-Related Osteomalacia: A Case Report
por: Oe, Yuki, et al.
Publicado: (2021)

THU440 A Case Of Osteomalacia In A Young Adult Female With Premature Ovarian Insufficiency
por: Kasimoglu, Ismail Hakki, et al.
Publicado: (2023)

MON-504 Osteomalacia During Pregnancy: Are Preventive Measures Enough to Avoid Future Fractures and Fetal Complications?
por: Pujals Kury, Jean, et al.
Publicado: (2019)

PSAT218 Technetium 99m-Methyl Diphosphonate (99mTc MDP) Radioguided Surgery in Patient With Tumor-Induced Osteomalacia (TIO)
por: Khan, Sara A, et al.
Publicado: (2022)

PSAT223 A Delayed Diagnosis of Oncogenic Osteomalacia Presenting with Bone Pain, Muscle Weakness and Elevated Alkaline Phosphatase
por: Gastelum, Alheli Arce, et al.
Publicado: (2022)

OR13-1 Long-Term Burosumab Therapy Provides Sustained Benefit in Patients with Tumor-Induced Osteomalacia: End of Study Findings From the Pivotal Phase 2 Study
por: Carpenter, Thomas, et al.
Publicado: (2022)

Response of Severe Osteomalacia to High Dose Vitamin D3 Replacement in a Patient With Ulcerative Colitis and Liver Transplantation on Immunosuppressive Therapy
por: Azmath, Misbah, et al.
Publicado: (2021)

Parathyromatosis Recurrent Hyperparathyroidism and Refractory Hypercalcemia Successfully Managed With Addition of Denosumab: A Case Report
por: Alhammad, Zahrah Abbas, et al.
Publicado: (2021)

PSAT182 Dilemmas in the Diagnosis and Management of Osteoporosis in a patient with Alkaptonuria: Successful Treatment with Teriparatide
por: Ebrahim, Ismail, et al.
Publicado: (2022)

SAT258 Successful Treatment Of Adult T-cell Leukemia-lymphoma Induced Hypercalcemia With Denosumab
por: Yuksel, Simge, et al.
Publicado: (2023)

ODP566 Success of CME at Improving Knowledge, Competence and Confidence Related to Guideline-Based Diagnosis and Management of Acromegaly
por: Carothers, Ann, et al.
Publicado: (2022)

MON-LB088 Comparative Study of Single Photon Emission Computed Tomography (SPECT)/CT Imaging Versus Combined Planar Technetium-99m Sestamibi -Ultrasonographic Imaging for Pre-Operative Parathyroid Localisation in Primary Hyperparathyroidism.
por: Rehman, Shoib Ur, et al.
Publicado: (2019)

THU434 A Case Of An Atypical Femur Fracture Managed Medically With Teriparatide
por: Rupani, Sawan V, et al.
Publicado: (2023)

Hypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case Report
por: Gandhi, Anand, et al.
Publicado: (2021)

THU455 Sclerostin Inhibitor Use In The Medical Management Of Osteogenesis Imperfecta Type III
por: Lundholm, Michelle Diane, et al.
Publicado: (2023)

MON-541 Successful Treatment of Normocalcemic Hyperparathyroidism in Children
por: Papadimitriou, Dimitrios, et al.
Publicado: (2019)

Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021)

MON-513 Osteonecrosis after Successful Osseointegrated Dental Implantation
por: Belany, Paul, et al.
Publicado: (2019)

PSAT203 Acquired Resistance to Medical Management in a Patient with Parathyroid Crisis due to a Parathyroid Adenoma
por: Kant, Ravi, et al.
Publicado: (2022)

ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
por: Mangaraj, Swayamsidha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0avq524mulkgujcao9uoc2aute